Dermata Therapeutics, Inc. (DRMA) Misses Q1 EPS by 207c

Dermata Therapeutics, Inc. (NASDAQ: DRMA) reported Q1 EPS of ($2.27), $2.07 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Dermata Therapeutics, Inc. (DRMA) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• TD Bank shares rise on higher fiscal Q3 earnings and revenue
• Best Buy (BBY) Tops Q2 EPS by 12c, Offers Guidance